Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

GI197111X is best dissolved in Capmul MCM for trials.

Ixekizumab has known and some unexpected side effects.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Increasing olanzapine caused hair loss in a woman, which stopped after changing medication.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Biologics for severe asthma have known side effects, but some new risks need more study.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Jujube fruit extract may reduce kidney damage from ibuprofen in rats.

Hydroxychloroquine may help COVID-19 patients with lupus.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.